Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New antitumor antibiotics aclacinomycins A and B.

× No keyword cloud information.

32 in total

Review 1. A comprehensive review of glycosylated bacterial natural products.

Authors: Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal: Chem Soc Rev Date: 2015-11-07 Impact factor: 54.564

2. Inhibitors of the cleavage of aclacinomycins.

Authors: U Gräfe; K Dornberger; W F Fleck; G Schumann
Journal: Biotechnol Lett Date: 1987-12 Impact factor: 2.461

3. The development of new anticancer drugs.

Authors: F M Arcamone
Journal: World J Microbiol Biotechnol Date: 1992-12 Impact factor: 3.312

4. Plasma kinetics of aclacinomycin A and its major metabolites in man.

Authors: M J Egorin; D Van Echo; B M Fox; M Whitacre; N R Bachur
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

5. Moromycins A and B, isolation and structure elucidation of C-glycosylangucycline-type antibiotics from Streptomyces sp. KY002.

Authors: Mohamed S Abdelfattah; Madan Kumar Kharel; John Andrew Hitron; Irfan Baig; Jürgen Rohr
Journal: J Nat Prod Date: 2008-07-31 Impact factor: 4.050

6. Phase II trial of aclacinomycin A in acute leukemia and various solid tumors.

Authors: J Schütte; N Niederle; S Seeber
Journal: J Cancer Res Clin Oncol Date: 1983 Impact factor: 4.553

7. Elevation of serum lipid peroxide level associated with doxorubicin toxicity and its amelioration by [dl]-alpha-tocopheryl acetate or coenzyme Q10 in mouse (doxorubicin, toxicity, lipid peroxide, tocopherol, coenzyme Q10).

Authors: N Yamanaka; T Kato; K Nishida; T Fujikawa; M Fukushima; K Ota
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

8. Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia.

Authors: G Mathé; M Bayssas; J Gouveia; D Dantchev; P Ribaud; D Machover; J L Misset; L Schwarzenberg; C Jasmin; M Hayat
Journal: Cancer Chemother Pharmacol Date: 1978 Impact factor: 3.333

Review 9. Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors: J Bouma; J H Beijnen; A Bult; W J Underberg
Journal: Pharm Weekbl Sci Date: 1986-04-25

10. Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia.

Authors: E Nagura; K Kimura; K Yamada; K Ohta; T Maekawa; F Takaku; H Uchino; T Masaoka; I Amaki; K Kawashima
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333